Amneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds will be used to build two new manufacturing facilities in Ahmedabad, focusing on peptide synthesis and advanced sterile fill-finish manufacturing.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.